Cue Biopharma (CUE) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.3
-2.22
-1.15
-0.07

Details

Expected EPS
-3.3
Actual EPS
-1.08
Surprise EPS
2.22
Surprise Percent
+67.27%

Description

Cue Biopharma (CUE) has reported earnings of -1.08 per share for Q2 2026.

0 Comments

Share your thoughts